News Snapshot:
Chinese COVID Vaccine On Hold, Sri Lanka To Use India’s Covishield For Now Chinese COVID Vaccine On Hold, Sri Lanka To Use India’s Covishield For Now 0 Share Colombo: Sri Lanka has decided to put China’s Sinopharm COVID-19 vaccine on hold and use India’s Serum Institute of India (SII)-manufactured Oxford-AstraZeneca vaccine Covishield to inoculate 14 million people. According to Sri Lanka’s Cabinet spokesperson Dr Ramesh Pathirana, the China is yet to complete phase 3 clinical trials of the Sinopharm vaccine. “For the time being, we need to go with the AstraZeneca vaccine. The moment we receive full documentation from the...
